Findings indicate elevated neutrophil-to-lymphocyte ratio and LDH predict poorer survival in melanoma, suggesting new prognostic tools.
ECOG PS ≥2 and elevated NLR were associated with no clinical benefit, while elevated NLR and LDH independently predicted poorer survival. These markers may serve as practical prognostic tools in metastatic melanoma treated with ICIs.
No takes yet. Share an insight, caveat, or question.
Wijaya et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: